in the coming week even if you do take a sick day mornings with maria six-9:00 a.m. eastern on foxbusiness every weekday. i will see you on sunday on fox news channel 10:00 a.m. eastern. i have interviews with house oversight committee rnc chairwoman and former u.s. chain -- trade representative. that will do it for us on foxbusiness. have a great rest of the weekend thank you so much for bein me and i will see you next time. ♪

♪ >> welcome. coming up, not so fast. when the right time is to buyer cash out. the hype around ai. too sure to determine the sure winners but we will tell you a few stocks to watch closely. wall street tools picking his next pair of kicks. stocks ended down by more than 2 % this week driven by interest rate concerns in china's weak economic growth. fixed mortgage rates climbing past 7%. warren buffett bought into home stocks. now is the time to follow his lead. covid vaccine demand is fizzling out. now may be the time to buy. elizabeth o'brien. jack, up this week, the 10 year

passing. >> a 15 year high. stocks fell for the week. 4.3%, not that high in historical terms. the average is close to 6%. a lot higher than where we were and that has investors nervous. the s&p is competition for stocks. it is not cheap. second-quarter earnings came down 3%. the third quarter will be flat. we will see. next year up 12%. that is not going to happen. a placeholder number that they stick their. closer to the end of the year they will give you the real number. >> who are some of the big winners? >> the big losers, cvs boss 10% on the week.

blue shield of california said it was dropping the pharmacy benefits management service in order to save money. apparently blue shield is getting rid of it. tesla had a bad week. a bad month. you can squint and find other concerns, worried about the economy. citizens financial group, a bunch of banks. those banks are facing tougher oversight. there are concerns complaining they were so low. they run up too quickly. >> you know how you save money, shorter receipts. we have the big annual jackson wyoming economist. interesting numbers to chew on.

including this project in a 5.8% gdp growth. >> right. the world capital of monetary policy wyoming. fed shared jerome powell will give a big speech. i expect him to say everything is still a little bad, but not as bad as it was a year ago. don't expect great cuts. don't think or feel anything. [laughter] >> hoping elizabeth can be a little bit more definitive. a longer fan of housing. >> that is right. we learned that berkshire hathaway bought a stake in dr horton. the country's largest homebuilder. up about 40% for the year as buyers have flocked to new construction. anybody that is looked for a home knows there is not much inventory out there. sellers have sat on the sidelines.

people with the mortgage rate of 3% are not too eager to trade that for 7%. dr horton chairs fell later in the week as we learned and hit a record year high. homebuilder stocks and learn to shrug it off. it seems like it finally caught up to them. >> recommending homebuilders as early as last year. >> indeed. bullish on homebuilders. he named toll brothers one of his pics. homebuilders bottom-line has had a good run. a little too late for a bit -- a little too late to call them into this. >> rates can go as high as 8%. >> that is true. >> covid. we think, we hope maybe it is kind of behind us. certainly less excitement about vaccines. >> the big winners during the pandemic are both down significantly double digits this year.

down 40% on the year because even though cases are creeping up, people are less concerned about getting it. the likelihood as many people will get boosters is probably a little less, to. >> doesn't mean it's a good time to get in the stocks? >> we have to give credit to andrew who took a look at both of them. balance sheets looking very strong. very little debt to no debt on both. nearly 75% of the market cap is in cash right now. these companies are not one trick ponies. they are developing vaccines for other viruses. rsv, the flu, things like that and also cancer treatment. you are looking at companies that have sold off. pretty cheap right now. they have other drugs in the pipeline. barron: if you want a broader look, that is way down. thank you. shares have soared on a i

excitement. valuation guru showing us the math next.

[ applause ] the day you get your clearchoice dental implants changes your struggle with missing teeth forever. it changes how you eat, how you feel, and how you enjoy life. it changes your smile and how others smile at you. clearchoice network doctors have changed over 100,000 lives with dental implants, and they can change yours, too. because a clearchoice day changes every day. schedule a free consultation.

(psst psst) ahhhh... with flonase, allergies don't have to be scary spraying flonase daily gives you long-lasting, non-drowsy relief. (psst psst) flonase. all good. shares have soared as tech companies sell up there intelligence. the market as a whole gone too far? joining me now is school of business finance professor better known as the dean of evaluation. thank you for coming on the show >> thanks for having me on. i would just like to ask you about the overall market. stocks about 15% this year. earnings are pretty much dead in

the water. is it possible to say how you feel about the valuation of the market as a whole? >> it is a combination. just two weeks ago i was on cnbc everything was amazing. two weeks later, this has been the last year and a half. if the market overreaches then it corrects. to be honest i think i would prefer to be consistently wrong and never change course. >> also everything is dismal. let's turn to this. very happy about that stock. a really interesting way of looking at this. can you break down. >> we look at this.

the business itself is mature. this is no longer the business overall. the last decade that has allowed them to set themselves apart. you look at intel. talking about conductors. they don't benefit the same. the company has been incredibly opportunistic. it has found big markets ahead of time. it has exceeded by being their first. the gaming business. the crypto business and now you have the ai business. all three businesses managing to be the first one there. dominating at least the start -- at least the starting. that is the thing that keeps where it is going. they will find a way to get the next big market going. you look at the market they are.

not big enough to justify the market cap of the company. >> in other words to justify this price not only do they have to keep dominating this but they have some new thing we have noto dominate that as well. >> i will not talk about this, they need to recognize the ability that there will be another big market out there, we don't even know about it yet. >> even better, a specific stock , expectations do not require that many things do go right. >> less mistakes. risk and opportunity are tied together. the least trouble forecasting the future are the businesses where we can find the fewest

mistakes. in a sense i do think it does make sense to try to get their hands around the ai business and what is coming. try to see if they can find it early in the process. i think that there is a payoff to doing your homework and dealing with the data. >> can you name a sector that was fairly valued? >> this is not the 1999 market. or even the 2007 market. it is a market that is overreaching. and is overreaching because two weeks ago the presumption that we are in for a stop -- we are in for a soft landing. it will not be that easy. three steps forward, two steps back. we will keep getting data that

makes us rethink those assumptions. i don't think that the market is the kind of market you look at and say i am staying here altogether. you have to choose. a sector being damaged significantly and you say now is a time to get it. >> fixed income portions of the portfolio giving you something these days. thank you so much. >> thank you for having me. >> artificial intelligence really is expected to change the way we work and live. taking a look at the rapidly detect this: living with hiv, i learned that i can stay undetectable with fewer medicines. that's why i switched to dovato. dovato is a complete hiv treatment for some adults. no other complete hiv pill

uses fewer medicines to help keep you undetectable than dovato. detect this: most hiv pills contain 3 or 4 medicines. dovato is as effective with just 2. if you have hepatitis b, don't stop dovato without talking to your doctor. don't take dovato if you're allergic to its ingredients or taking dofetilide. this can cause serious or life-threatening side effects. if you have a rash or allergic reaction symptoms, stop dovato and get medical help right away. serious or life-threatening lactic acid buildup and liver problems can occur. tell your doctor if you have kidney or liver problems or if you are pregnant, breastfeeding, or considering pregnancy. dovato may harm an unborn baby. most common side effects are headache, nausea, diarrhea, trouble sleeping, tiredness, and anxiety. detect this: i stay undetectable with fewer medicines. ask your doctor about switching to dovato.

if you have heart disease and are on a statin, lowering cholesterol can be hard. diets and exercise add to the struggle. today, it's possible to go from struggle to cholesterol success with leqvio. with a statin, leqvio is proven to lower bad cholesterol by over 50% and keep it low with two doses a year. common side effects were injection site reaction, joint pain, urinary tract infection, diarrhea, chest cold, pain in legs or arms, and shortness of breath. ask your doctor about twice-yearly leqvio. lower. longer. leqvio. ♪

a group of experts. tell us what you learned. >> a lot of roundtables over the years. we had a really wide gamut of people. adventure capitalist, two executives from legacies and start ups. despite that diversity of factors, everyone seemed to agree that ai presented some issues and some risks for the most part. this was a game changer. signing the important problems. >> you a kind of been dubious but i assume you're kind of jazzed.

>> it is true. at the time i was really focused on what everyone was talking about. i played with it for a few months, it is kind of a novelty. it is cool, it is fun. it is not that useful in everyday life. i learned from this roundtable is that chap bots are the least of it. how we are finding new ways to use that with these large language models. automatically labeling everything in history and we are able to call it out. >> we just heard the professor talk about this. having to dominate ai and something else. >> no one really seems to want to get in front of it. i feel like they were a little bit mixed on the company. up almost 200% this year.

40% forward earnings. i think that there is some scarcity value. it really is the only company out there that is actually seeing a financial impact. all of these companies out there all the cloud companies are buying up chips for their future . i think that that is why they have done so much excitement. the world is going to change and it is at the forefront and it's time to put a price on that. >> marsha marsha marsha. can you tell me is there any other company that we can be watching in the ai space. >> the one from our roundtable that really caught my attention was adobe. all of this creative software.

you can -- and they are doing great things with ai. you can try the version right now and type in, into a text prompter or request to say put the statue of liberty -- statue of liberty behind your child. it really does feel magical what they are doing right now. the coolest thing is they are confident that they have the right for all the images they are putting into their ai stuff basically. they cannot be sued for it. that is a big deal. one of the biggest risks right now in ai is no one knows who owns anything and if you are company and you start using ai you could get sued. finding a way that you can let it happen using our products.

existential threats to humanity. ai creating deep think videos. ai replacing jobs leading to mass unemployment or an arms race between china, the u.s. and russia. controlling autonomous weapon systems. can the government try and see me from my phone? >> they are scary sounding. i think what is happening right now putting out a lot of these fear mongering -- mongering headlines from the industry. they were almost offended by this. we did ask about the x essential threat. people doing this are basically trying to push regulations in a way that will help the incumbents.

>> all humans. >> everybody wiping out a ton of jobs including my own. i am hoping that our job is safe for the foreseeable future. people thought that the product to 50 would be a net positive for so society. creating more jobs and we lose. >> trying to keep our jobs with some great investment ideas. using sophisticated financial analysis. that will be next. meet the team all using chase to keep up with their finances. smart bankers. convenient tools. boom. one bank with the power of both. chase. make more of what's yours.

with a majority of my patience with sensitivity, i see irritated gums and weak enamel. sensodyne sensitivity gum & enamel relieves sensitivity, helps restore gum health, and rehardens enamel. i'm a big advocate of recommending things that i know work. salonpas lidocaine flex. a super thin, flexible patch with maximum otc strength lidocaine that contours to the body to relieve pain right where it hurts. and did we mention, it really, really sticks? salonpas, it's good medicine.

before... and bath fitter. now's the time to call bath fitter to get a beautiful “after.” with our unique tub over tub process, there's no mess or stress. bath fitter. it just fits. visit bathfitter.com to book your free consultation.

♪

jack, you probably do not realize i am a super trendy guy. those adidas i've been wearing since college are pretty cool. >> they are coming back. trying to find cool sneakers. i am a new balance man. that is not a plug. i am trying to find some heat using other methods here. that was owned by deckers out door. that is a pretty hot shoe. that is a swiss shoe. up 52% revenue last quarter. following the nike and new balance. following for elite runners. >> the souls are about that high >> they are like moon boots.

that is like 14% this week. blowout results. they call it a buyout opportunity. they did acquire adidas this week. they've had a lot of turnover plans. if i had to put a name on a new plan -- old shoes -- [laughter] blowing out the kanye shoes. they used to be athletic shoes and now therefore loafing around >> they do say that? >> let's go to stock picks. you have an interesting one. >> taking a look, and a lot of bids coming in at $35 a share. ending at $31 a share. there will be some action in this stock. don't know quite where it will

go. the stock had traded around 40% a year ago. definitely wanted to keep an eye on it. >> a long time ago. elizabeth, what do you have for us? >> we may see an upside surprise like we got with home depot this past week. low mortgage rates stuck in their homes. spending money to make themselves feel better. >> that makes sense. thanks, guys. check out this week's edition. down forget to follow us on x formally known as twitter. we will see you next ♪ maria: happy weekend to all. welcome to t